The results of the 2010 Avoca industry survey illustrate widespread recognition of the need for efficient and high-performing
outsourcing practices in the clinical drug-development industry. Feedback provided in this survey suggests that both sponsor
and clinical service provider companies currently are making, or intend soon to make, wide-ranging changes in the way they
conduct their outsourcing business. Among the changes planned or underway, major themes that emerged include the consolidation
of outsourcing activities within long-term preferred-provider relationships, higher expectations of these relationships, and
increased investment in formal measurement and management of performance and relationship quality.
The potential benefits associated with such changes in approach appear to be appreciated by sponsors and clinical service
providers alike, and based on the data collected, each of these changes appears already to be underway within the industry.
Both direct reports from respondents about their experiences, and associations in the data between the use of these approaches
and increased satisfaction with provider performance and value, suggest that these approaches, when implemented in a high-quality
manner, do in fact yield greater outsourcing quality, value, and overall relationship satisfaction.
Denise Calaprice-Whitty, PhD, is executive director of survey research at the Avoca Group, 179 Nassau St., Suite 3A, Princeton, NJ 08542, tel. 909.337.2848,
1. Avoca Group, "The 2009 Avoca Report: Trends in Clinical Outsourcing" (Princeton, NJ, 2009)
2. Avoca Group, "The 2010 Avoca Report: Trends in Clinical Outsourcing" (Princeton, NJ, 2010)